Global Anti-Hypertensive Drugs and Therapeutics Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027
MarketResearch.biz delivers in-depth insights on the global anti-hypertensive drugs and therapeutics market in its upcoming report titled, “Global Anti-Hypertensive Drugs and Therapeutics Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global anti-hypertensive drugs and therapeutics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global anti-hypertensive drugs and therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global anti-hypertensive drugs and therapeutics market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global anti-hypertensive drugs and therapeutics market report has been segmented on the basis of therapeutics, and region.
Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. Hypertension arises when diastolic and systolic pressure persistently reaches or is above the 140/90mm Hg level. Moreover, hypertension is mainly caused due to change in lifestyle habits such as diet, smoking and alcohol intake. The anti-hypertensive drugs play important role in the treatment of high blood pressure, hypertension in patients.
High incidence of hypertension, and elevation in stress levels among young population are key factors driving the anti-hypertensive drugs and therapeutics market. In addition, changing lifestyle, food habits, and increasing awareness among individuals about hypertension and antihypertensive drugs are major factors contributing to growth of the global anti-hypertensive drugs and therapeutics market.
However, patent expiry on major drugs such as Diovan, Cozar, and Revatio is a key restraint for growth of the global anti-hypertensive drugs and therapeutics market. In addition, low diagnostics rate and increased generic penetration are major factors hampering growth of the global anti-hypertensive drugs and therapeutics market.
A steady increase in pulmonary arterial hypertension and use of fixed dose combination therapies is expected to drive growth of the antihypertensive market over the forecast period. Moreover, launch of novel drug therapies with improved safety and efficacy could also contribute to growth of the global antihypertensive drugs and therapeutics market.
Currently, the market in North America dominates the global anti-hypertensive drugs and therapeutics market in revenue terms owing to increasing incidence of hypertension and existence of a large patient pool. Europe is currently the second-largest market due to increasing awareness among general population, and presence of a large geriatric population. The market in Asia Pacific is expected to witness relatively high growth over the forecast period owing to high incidences of cardiovascular diseases, improving healthcare infrastructure, and increasing government funding for R&D in the region.
Global anti-hypertensive drugs and therapeutics market segmentation by therapeutics:
- Angiotensin receptor blockers (ARBs)
- Angiotensin converting enzyme (ACE) inhibitors
- Beta blockers
- Alpha blockers
- Calcium channel blockers
- Renin inhibitors
Global anti-hypertensive drugs and therapeutics market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Novartis AG
- Pfizer Inc.
- Sanofi S.A
- Johnson & Johnson Ltd.
- Daiichi - Sankyo
- Merck & Co.
- AstraZeneca Plc.
- Ranbaxy Laboratories Limited
- Lupin Limited
- Takeda Pharmaceutical Company Limited
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!